White Paper "Spatial Phenotypic Signatures: A novel biomarker class for characterizing solid tumors and predicting immunotherapy response"

The spatial phenotypic signature, a new biomarker class, continues to demonstrate its predictive value for identifying patients who have a positive response to immunotherapy. Find out how this innovative biomarker testing approach is moving us closer to personalized medicine.

Complete this form to download the white paper.

"*" indicates required fields

Name*

First Name *

Last Name *

Organization*

Country*

State*

Province*

Postal Code*

Email*

Phone

Do you own or have access to any of the following instruments? (Choose one)*

PhenoCycler-Fusion or PhenoCycler (formerly, CODEX)

PhenoImager Fusion or PhenoImager HT (formerly, Vectra Polaris)

Both PhenoCycler and PhenoImager Platforms

None of the above

What analyte type or panel composition would you be interested in adopting? (Choose one)*

Protein markers only

Primarily protein with a handful of RNA markers

Primarily RNA with a handful of protein markers

RNA markers only

Not sure yet

Contact Me

I’d like to speak with a specialist about Akoya’s spatial biology solutions

By registering on this web page, you are consenting and agreeing to collection and use of your information by Akoya Biosciences in accordance with its Privacy Policy.

Download the white paper to learn how spatial phenotypic signatures:

Reveal correlations between cell types and expression patterns

Provide insight into the tumor microenvironment

Advance precision medicine with high predictive value

Akoya Biosciences and The Spatial Biology Company are registered trademarks of Akoya Biosciences, Inc. A Delaware corporation. Copyright © 2024 All Rights Reserved. Terms and Conditions Privacy Policy Do Not Sell or Share My Personal Information Modern Slavery Act Statement